From: Transgenic rat models for mutagenesis and carcinogenesis
| Agents | Animal | Dose | Route | Sex | Age (weeks) | Administration time/Sampling time (days) | Tissue | Transgenic assays | Positive response | Reference |
|---|---|---|---|---|---|---|---|---|---|---|
| Acetaminophen | gpt delta rat (SD) | 10000 ppm | Diet | Female | 11 | 91/91 | Liver | gpt | - | [167] |
| Acrylamide | Big Blue rat (F344) | 1.4 mM | Drinking water | Male | 7 | 60/60 | Liver | cII | - | [168] |
| Bone marrow | cII | - | Ibid | |||||||
| Thyroid | cII | - | Ibid | |||||||
| Testis | cII | Ibid | ||||||||
| gpt delta rat (F344) | 0.7 mM | Drinking water | Female | 7 | 60/60 | Liver | cII | - | Ibid | |
| Bone marrow | cII | + | Ibid | |||||||
| Thyroid | cII | + | ibid | |||||||
| Mammary gland | cII | - | Ibid | |||||||
| Male | 7 | 60/60 | Liver | cII | - | Ibid | ||||
| Female | 7 | 60/60 | Liver | cII | - | Ibid | ||||
| 80 ppm | Drinking water | Male | 3 | 28/28 | Testis | gpt | + | [169] | ||
| Liver | gpt | - | Ibid | |||||||
| 40 ppm | Testis | gpt | - | Ibid | ||||||
| Liver | gpt | - | Ibid | |||||||
| 20 ppm | Testis | gpt | - | Ibid | ||||||
| Liver | gpt | - | Ibid | |||||||
| 80 ppm | Drinking water | Male | 11 | 28/28 | Testis | gpt | - | Ibid | ||
| Liver | gpt | - | Ibid | |||||||
| 40 ppm | Testis | gpt | - | Ibid | ||||||
| 20 ppm | Liver | gpt | - | Ibid | ||||||
| Testis | gpt | - | Ibid | |||||||
| Liver | gpt | - | ibid | |||||||
| Aflatoxin B1 | Big Blue rat (F344) | 0.5 mg/kg | Gavage | Male | 13 | 1/14 | Liver | lacI | + | [105] |
| Female | 13 | 1/14 | Liver | lacI | + | Ibid | ||||
| 0.5 mg/kg | Gavage | Female | 6–8 | 1/14 | Liver | lacI | + | [170] | ||
| cII | + | [109] | ||||||||
| 0.25 mg/kg | Intraperitoneal | Male | 13–19 | 1/14 | Liver | lacI | + | [18] | ||
| 2-Amino-3-methylimidazo[4,5-f]quinoline (IQ) | Big Blue rat (F344) | 20 mg.kg | Gavage | Male | 5 | 1/14 | Liver | lacI | + | [171] |
| Colon | lacI | + | Ibid | |||||||
| Kidney | lacI | + | Ibid | |||||||
| 20 mg/kg x5 | Gavage | Male | 5 | 5/18 | Liver | lacI | + | Ibid | ||
| Colon | lacI | + | Ibid | |||||||
| Kidney | lacI | + | Ibid | |||||||
| 200 ppm | Diet | Male | 8 | 21/21 | Liver | cII | + | [172] | ||
| Colon | cII | + | Ibid | |||||||
| 70 ppm | Diet | Male | 8 | 21/21 | Liver | cII | + | Ibid | ||
| Colon | cII | + | Ibid | |||||||
| 9–12 | 21/21 | Liver | cII | + | [100] | |||||
| Colon | cII | + | Ibid | |||||||
| 20 ppm | Diet | Male | 8 | 21/21 | Liver | cII | - | [172] | ||
| Colon | cII | - | Ibid | |||||||
| gpt delta rat (SD) | 300 ppm | Diet | Female | 11 | 91/91 | Liver | gpt | + | [167] | |
| 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) | Big Blue rat (F344) | 100 ppm | Diet | Male | 6 | 112/112 | Liver | lacI | + | [85] |
| Colon | lacI | + | Ibid | |||||||
| Zymbal gland | lacI | + | Ibid | |||||||
| Kidney | lacI | - | Ibid | |||||||
| Spleen | lacI | - | Ibid | |||||||
| Lung | lacI | - | Ibid | |||||||
| Testis | lacI | - | Ibid | |||||||
| Heart | lacI | - | Ibid | |||||||
| Brain | lacI | - | Ibid | |||||||
| Fat tissue | lacI | - | Ibid | |||||||
| Skeletal muscle | lacI | - | Ibid | |||||||
| 10 ppm | Diet | Male | 6 | 112/112 | Liver | lacI | + | Ibid | ||
| 1 ppm | Diet | Male | 6 | 112/112 | Liver | lacI | - | Ibid | ||
| 0.1 ppm | Diet | Male | 6 | 112/112 | Liver | lacI | - | Ibid | ||
| 0.01 ppm | Diet | Male | 6 | 112/112 | Liver | lacI | - | Ibid | ||
| 0.001 ppm | Diet | Male | 6 | 112/112 | Liver | lacI | - | Ibid | ||
| 2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP) | Big Blue rat (F344) | 100 mg/kg, bw | Intraperitoneal | Male | 8+22 | 1/14 | Colon | lacI | + | [102] |
| Female | 8+22 | 1/14 | Colon | lacI | + | Ibid | ||||
| 75 mg/kg ×10 | Oral | Female | 7 | 12/54 | Mammary gland | lacI | + | [40] | ||
| 22 | 12/54 | Mammary gland | lacI | + | Ibid | |||||
| 70 mg/kg ×12 | Gavage | Male | 13–15 | 28/30 | Liver | cII | - | [41] | ||
| Kidney | cII | - | Ibid | |||||||
| Prostate | cII | + | Ibid | |||||||
| Seminal vesicle | cII | + | Ibid | |||||||
| Colon | cII | + | Ibid | |||||||
| Spleen | cII | + | Ibid | |||||||
| 70 mg/kg ×24 | Gavage | Male | 13–15 | 56/60 | Liver | cII | - | Ibid | ||
| Kidney | cII | - | Ibid | |||||||
| Prostate | cII | + | Ibid | |||||||
| Seminal vesicle | cII | + | Ibid | |||||||
| Colon | cII | + | Ibid | |||||||
| Spleen | cII | + | Ibid | |||||||
| 400 ppm | Diet | Male | 6 | 60/67 | Colon mucosa | lacI | + | [23, 44] | ||
| cII | + | [23] | ||||||||
| Female | 6 | 60/67 | Colon mucosa | lacI | + | [23, 44] | ||||
| cII | + | [23] | ||||||||
| 200 ppm | Diet | Male | 7 | 61/68 | Distal colon | lacI | + | [45, 173] | ||
| Proximal colon | lacI | + | Ibid | |||||||
| Cecum | lacI | + | Ibid | |||||||
| Prostate | lacI | + | [42] | |||||||
| Female | 7 | 61/68 | Distal colon | lacI | + | [45] | ||||
| Proximal colon | lacI | + | Ibid | |||||||
| Cecum | lacI | + | Ibid | |||||||
| 100 ppm | Diet | Male and Female | 7 | 47/54 | Distal colon | lacI | + | [174] | ||
| Cecum | lacI | + | Ibid | |||||||
| Male | 7 | 47/54 | Kidney | lacI | + | [98] | ||||
| Female | 7 | 47/54 | Kidney | lacI | + | Ibid | ||||
| Big Blue rat (F344 × SD)F1 | 65 mg/kg ×10 | Gavage | Female | 6 | 12/350–441 | Mammary gland | lacI | + | [39] | |
| Amosite asbestos | Big Blue rat (F344) | 2 mg/rat | Intratracheal | Male | 11 | 1/28 | Lung | lacI | - | [103, 126] |
| 1/112 | Lung | lacI | + | Ibid | ||||||
| 2 mg/rat ×4 | Intratracheal | Male | 11 | 28/56 | Lung | lacI | - | Ibid | ||
| 28/133 | Lung | lacI | + | Ibid | ||||||
| 1 mg/rat | Intratracheal | Male | 11 | 1/28 | Lung | lacI | - | Ibid | ||
| 1/112 | Lung | lacI | - | Ibid | ||||||
| Aristolochic acid | Big Blue rat (F344) | 10 mg/kg | Gavage | Male | 6 | 84/84 | Kidney | cII | + | [112, 113] |
| Liver | cII | + | [112] | |||||||
| Testis | cII | - | [175] | |||||||
| 1.0 mg/kg | Gavage | Male | 6 | 84/84 | Kidney | cII | + | [112, 113] | ||
| Liver | cII | + | [112] | |||||||
| 0.1 mg/kg | Gavage | Male | 6 | 84/84 | Kidney | cII | + | [112, 113] | ||
| Liver | cII | - | [112] | |||||||
| Big Blue rat (F344) | 10 mg/kg | Gavage | Male | 6 | 84/84 | Spleen | cII | + | [176] | |
| 1.0 mg/kg | Gavage | 6 | 84/84 | Spleen | cII | + | Ibid | |||
| 0.1 mg/kg | Gavage | 6 | 84/84 | Spleen | cII | - | Ibid | |||
| gpt delta rat (F344) | 1 mg/kg | Gavage | Male | 7 | 28/31 | Kidney | gpt | + | [177] | |
| 0.3 mg/kg | Gavage | 7 | 28/31 | Liver | gpt | + | Ibid | |||
| Benzo[a]pyrene (BP) | Big Blue rat (F344) | 100 mg/kg, bw | Intraperitoneal | Male | 8+22 | 1/14 | Liver | lacI | + | [102] |
| Female | 8+22 | 1/14 | Liver | lacI | + | Ibid | ||||
| 5 mg/rat | Intraperitoneal | Female | 10 | 1/28 | Omentum | lacI | + | [178] | ||
| 1/84 | Omentum | lacI | + | Ibid | ||||||
| 1/168 | Omentum | lacI | + | Ibid | ||||||
| gpt delta rat (SD) | 125 mg/kg | Intraperitoneal | Male | 9–10 | 1/7 | Liver | gpt | + | [17] | |
| Spi– | + | Ibid | ||||||||
| 62.5 mg/kg | Intraperitoneal | Male | 9–10 | 1/7 | Liver | gpt | + | Ibid | ||
| Spi− | - | Ibid | ||||||||
| Bitumen fumes | Big Blue rat (F344) | 6 hr ×5 | Inhalation | Male | 8 | 5/35 | Lung | cII | - | [132] |
| Ibid | ||||||||||
| N-butyl-N-(4-hydroxybutyl)nitrosamine | Big Blue rat (F344) | 0.05 % | Drinking water | Male | 8 | 14/42 | urothelial cells (urinary bladder) | cII | + | [179] |
| smooth muscle cells (urinary bladder) | cII | - | Ibid | |||||||
| Ureter | cII | - | Ibid | |||||||
| Kidney | cII | - | Ibid | |||||||
| Liver | cII | - | Ibid | |||||||
| 42/70 | urothelial cells (urinary bladder) | cII | + | Ibid | ||||||
| smooth muscle cells (urinary bladder) | cII | + | Ibid | |||||||
| Ureter | cII | - | Ibid | |||||||
| Kidney | cII | - | Ibid | |||||||
| Liver | cII | - | Ibid | |||||||
| Citrinin | gpt delta rat (F344) | 40 mg/kg (decreased to 30 mg/kg at day 4) | Gavage | Male | 28/31 | Kidney | gpt | - | [65] | |
| 20 mg/kg | 28/31 | Kidney | gpt | - | Ibid | |||||
| Comfrey | Big Blue rat (F344) | 2 % | Diet | Male | 6 | 84/84 | Liver | cII | + | [180] |
| Conjugated linoleic acid | Big Blue rat (F344) | 1 %(w/w) | Diet | Male and Female | 7 | 54/61 | Distal colon | lacI | - | [174] |
| Cecum | lacI | - | Ibid | |||||||
| Kidney | lacI | - | [98] | |||||||
| Crocidolite | Big Blue rat (F344) | 5 mg/rat | Intraperitoneal | Female | 10 | 1/28 | Omentum | lacI | - | [178] |
| 1/84 | Omentum | lacI | + | Ibid | ||||||
| 1/168 | Omentum | lacI | + | Ibid | ||||||
| 2 mg/rat | Intraperitoneal | Female | 10 | 1/28 | Omentum | lacI | - | Ibid | ||
| 1/84 | Omentum | lacI | - | Ibid | ||||||
| 1/168 | Omentum | lacI | - | Ibid | ||||||
| Cyproterone acetate | Big Blue rat (F344) | 160 mg/kg | Gavage | Female | 12 | 1/14 | Liver | lacI | + | [90] |
| 100 mg/kg | Gavage | Female | 12 | 1/1 | Liver | lacI | + | Ibid | ||
| 1/2 | Liver | lacI | + | Ibid | ||||||
| 1/3 | Liver | lacI | + | Ibid | ||||||
| 1/7 | Liver | lacI | + | Ibid | ||||||
| 1/14 | Liver | lacI | + | Ibid | ||||||
| 1/28 | Liver | lacI | + | Ibid | ||||||
| 1/42 | Liver | lacI | + | Ibid | ||||||
| 1/56 | Liver | lacI | + | Ibid | ||||||
| 80 mg/kg | Gavage | Female | 12 | 1/14 | Liver | lacI | + | Ibid | ||
| 40 mg/kg | Gavage | Female | 12 | 1/14 | Liver | lacI | + | Ibid | ||
| 20 mg/kg | Gavage | Female | 12 | 1/14 | Liver | lacI | + | Ibid | ||
| 10 mg/kg | Gavage | Female | 12 | 1/14 | Liver | lacI | + | Ibid | ||
| 5 mg/kg | Gavage | Female | 12 | 1/14 | Liver | lacI | - | Ibid | ||
| 5 mg/kg ×21 | Gavage | Female | 11–12 | 21/22 | Liver | lacI | + | [181] | ||
| 1.0 mg/kg ×21 | Gavage | Female | 11–12 | 21/22 | Liver | lacI | - | Ibid | ||
| 0.2 mg/kg ×21 | Gavage | Female | 11–12 | 21/22 | Liver | lacI | - | Ibid | ||
| Daidzein | Big Blue rat (F344) | 1 g/kg | Diet | Female | 7 | 112/112 | Mammary gland | lacI | - | [95] |
| Uterus | lacI | - | [96] | |||||||
| 0.25 g/kg | Diet | Female | 7 | 112/112 | Mammary gland | lacI | - | [95] | ||
| Uterus | lacI | - | [96] | |||||||
| Big Blue rat (F344), ovariectomized | 1 g/kg | Diet | Female | 7 | 112/112 | Uterus | lacI | - | [96] | |
| 0.25 g/kg | Diet | Female | 7 | 112/112 | Uterus | lacI | - | Ibid | ||
| Diallyl sulfide (DAS) | Big Blue rat (F344) | 200 mg/kg ×2 | Gavage | Male | 7–10 | 7/21 | Esophagus | lacI | - | [93] |
| 2,4-diaminotoluene (2,4-DAT) | gpt delta rat (F344) | 30 mg/kg | Gavage | Male | 7 | 28/31 | Liver | gpt | + | [55] |
| 10 mg/kg | Gavage | Male | 7 | 28/31 | Liver | gpt | + | Ibid | ||
| gpt delta rat (F344) | 500 ppm | Diet | Male | 7 | 91/91 | Liver | gpt, Spi− | + | [7] | |
| 500 ppm | Diet | Male | 7 | 91/91 | Kidney | gpt | - | Ibid | ||
| 250 ppm | Diet | Male | 7 | 91/91 | Liver | gpt, Spi− | + | Ibid | ||
| 250 ppm | Diet | Male | 7 | 91/91 | Kidney | gpt | - | Ibid | ||
| 125 ppm | Diet | Male | 7 | 91/91 | Liver | gpt | + | Ibid | ||
| 125 ppm | Diet | Male | 7 | 91/91 | Liver | Spi- | - | Ibid | ||
| 125 ppm | Diet | Male | 7 | 91/91 | Kidney | gpt | - | Ibid | ||
| 2,6-diaminotoluene (2.6-DAT) | gpt delta rat (F344) | 60 mg/kg | Gavage | Male | 7 | 28/31 | Liver | gpt | - | [55] |
| gpt delta rat (F344) | 500 ppm | Diet | Male | 7 | 91/91 | Liver | gpt, Spi− | - | [7] | |
| 500 ppm | Diet | Male | 7 | 91/91 | kideny | gpt | - | Ibid | ||
| 1,2,3,4-Diepoxybutane | Big Blue rat (F344) | 3.8 ppm, 6 hr ×5×2 | Inhalation | Female and Male | 6–8 | 14/49 | Spleen | lacI | - | [182] |
| 14/28 | Bone marrow | lacI | + | Ibid | ||||||
| Diesel exhaust (DE) | Big Blue rat (F344) | 6 mg SPM/m3, 12 hr/day | Inhalation | Male | 6 | 28/31 | Lung | lacI | + | [130] |
| 1 mg SPM/m3, 12 hr/day | Inhalation | Male | 6 | 28/31 | Lung | lacI | - | ibid | ||
| 80 mg DEP/kg | Diet | Male | 8 | 21/21 | Lung | cII | - | [131] | ||
| 20 mg DEP/kg | Diet | Male | 8 | 21/21 | Lung | cII | - | Ibid | ||
| 8 mg DEP/kg | Diet | Male | 8 | 21/21 | Lung | cII | - | Ibid | ||
| 2 mg DEP/kg | Diet | Male | 8 | 21/21 | Lung | cII | - | Ibid | ||
| 0.8 mg DEP/kg | Diet | Male | 8 | 21/21 | Lung | cII | - | Ibid | ||
| 0.2 mg DEP/kg | Diet | Male | 8 | 21/21 | Lung | cII | - | Ibid | ||
| Di(2-ethyl-hexyl)phthalate (DEHP) | gpt delta rat (SD) | 12000 ppm | Diet | Female | 11 | 91/91 | Liver | gpt | - | [167] |
| Spi− | - | Ibid | ||||||||
| Diethylnitrosamine | gpt delta rat (F344) | 20 mg/kg (once a week) | Intraperitoneal | Male | 7 | 91/91 | Liver | gpt, Spi− | + | [7] |
| Male | 7 | 91/91 | kidney | gpt | + | ibid | ||||
| 5-p-Dimethylaminophenylazobenzthiazole (5BT) | Big Blue rat (F344) | 10 mg/kg ×10 | Gavage | Male | 12 | 10/20 | Liver | lacI | + | [61] |
| 0.03 % | Diet | Male | 12 | 10/20 | Liver | lacI | + | ibid | ||
| 6-p-Dimethylaminophenylazobenzthiazole (6BT) | Big Blue rat (F344) | 10 mg/kg ×10 | Gavage | Male | 12 | 10/20 | Liver | lacI | + | [61, 183] |
| 0.03 % | Diet | Male | 12 | 10/20 | Liver | lacI | + | ibid | ||
| 7,12-Dimethylbenzanthracene (DMBA) | Big Blue rat (F344) | 130 mg/kg | Gavage | Female | 7 | 1/14 | Splenic lymphocyte | lacI | + | [27] |
| 1/14 | Mammary gland | lacI | + | [184] | ||||||
| 1/14 | Bone marrow | lacI | + | [26] | ||||||
| 1/42 | Splenic lymphocyte | lacI | + | [27] | ||||||
| 1/42 | Mammary gland | lacI | + | [184] | ||||||
| 1/42 | Bone marrow | lacI | + | [26] | ||||||
| 1/70 | Splenic lymphocyte | lacI | + | [27] | ||||||
| 1/70 | Mammary gland | lacI | + | [18] | ||||||
| 1/70 | Bone marrow | lacI | + | [26] | ||||||
| 1/98 | Splenic lymphocyte | lacI | + | [27] | ||||||
| 1/98 | Mammary gland | lacI | + | [184] | ||||||
| 1/98 | Bone marrow | lacI | + | [26] | ||||||
| 80 mg/kg | Gavage | Female | 7 | 1/112 | Liver | cII | + | [94] | ||
| Uterus | lacI | + | [96] | |||||||
| 75 mg/kg | Gavage | Female | 7 | 1/14 | Splenic lymphocyte | lacI | - | [27] | ||
| 1/42 | Splenic lymphocyte | lacI | + | Ibid | ||||||
| 1/70 | Splenic lymphocyte | lacI | + | Ibid | ||||||
| 1/98 | Splenic lymphocyte | lacI | + | Ibid | ||||||
| 1/126 | Splenic lymphocyte | lacI | - | Ibid | ||||||
| 20 mg/kg | Gavage | Female | 7 | 1/14 | Splenic lymphocyte | lacI | - | [27] | ||
| 1/14 | Mammary gland | lacI | - | [184] | ||||||
| 1/14 | Bone marrow | lacI | + | [26] | ||||||
| 1/42 | Splenic lymphocyte | lacI | + | [27] | ||||||
| 1/42 | Mammary gland | lacI | - | [184] | ||||||
| 1/42 | Bone marrow | lacI | + | [26] | ||||||
| 1/70 | Splenic lymphocyte | lacI | - | [27] | ||||||
| 1/70 | Mammary gland | lacI | - | [184] | ||||||
| 1/70 | Bone marrow | lacI | + | [26] | ||||||
| 1/98 | Splenic lymphocyte | lacI | - | [27] | ||||||
| 1/98 | Mammary gland | lacI | - | [18]) | ||||||
| 1/98 | Bone marrow | lacI | + | [26] | ||||||
| 1/126 | Splenic lymphocyte | lacI | - | [27] | ||||||
| 1/126 | Mammary gland | lacI | - | [184] | ||||||
| Big Blue rat (F344), ovariectomized | 80 mg/kg | Gavage | Female | 7 | 1/112 | Heart | lacI | + | [185] | |
| Liver | cII | + | [94] | |||||||
| Uterus | lacI | + | [96] | |||||||
| Dimethylnitrosamine (DMN) | Big Blue rat (F344) | 6.0 mg/kg ×9 | Gavage | Male | 12 | 11/12 | Liver | lacI | + | [20] |
| cII | + | Ibid | ||||||||
| 2.0 mg/kg ×9 | Gavage | Male | 12 | 11/12 | Liver | lacI | + | Ibid | ||
| cII | + | Ibid | ||||||||
| 0.6 mg/kg ×9 | Gavage | Male | 12 | 11/12 | Liver | lacI | - | Ibid | ||
| cII | - | Ibid | ||||||||
| 0.2 mg/kg ×9 | Gavage | Male | 12 | 11/12 | Liver | lacI | - | Ibid | ||
| cII | - | Ibid | ||||||||
| Big Blue rat (F344) | 25 ppm | Drinking water | 14/14 | Liver | cII | [186] | ||||
| 10 ppm | Drinking water | 14/14 | Liver | cII | Ibid | |||||
| 5 ppm | Drinking water | 14/14 | Liver | cII | Ibid | |||||
| 1 ppm | Drinking water | 14/14 | Liver | cII | Ibid | |||||
| 0.1 ppm | Drinking water | 14/14 | Liver | cII | Ibid | |||||
| Ellagic acid | Big Blue rat (F344) | 4 g/kg | Diet | Male | 7–10 | 42/42 | Esophagus | lacI | - | [93] |
| 1,2-Epoxy-3-butene | Big Blue rat (F344) | 29.9 ppm, 6 hr ×5×2 | Inhalation | Female | 6–8 | 14/49 | Spleen | lacI | - | [182] |
| 14/28 | Bone marrow | lacI | + | Ibid | ||||||
| Estragole | gpt delta rat (F344) | 600 mg/kg | Gavage | Male | 5 | 5 days per week x 4 weeks | Liver | gpt | (72) toxic but 2 of 5 survived rats showed positive responses | |
| 200 mg/kg | Gavage | Male | 5 | 5 days per week x 4 weeks | Liver | gpt | + | ibid | ||
| 66 mg/kg | Gavage | Male | 5 | 5 days per week x 4 weeks | Liver | gpt | - | Ibid | ||
| 22 mg/kg | Gavage | Male | 5 | 5 days per week x 4 weeks | Liver | gpt | - | Ibid | ||
| N-ethyl-N-nitrosourea (ENU) | Big Blue rat (F344) | 100 mg/kg | Intraperitoneal | Male | 8+22 | 1/14 | Liver | lacI | + | [102] |
| Female | 8+22 | 1/14 | Liver | lacI | + | Ibid | ||||
| gpt delta rat (SD) | 100 mg/kg | Intraperitoneal | Male | 5 | 1/7 | Liver | gpt | + | [17] | |
| Spi− | - | Ibid | ||||||||
| 50 mg/kg ×5 | Intraperitoneal | Male | 10 | 5/7 | Liver | gpt | + | Ibid | ||
| 5/21 | Liver | gpt | + | Ibid | ||||||
| 5/35 | Liver | gpt | + | Ibid | ||||||
| 5/70 | Liver | gpt | + | Ibid | ||||||
| 17beta-estradiol | Big Blue rat (F344) | 0.005 g/kg | Diet | Female | 7 | 112/112 | Mammary gland | lacI | - | [95] |
| Uterus | lacI | - | [96] | |||||||
| Big Blue rat (F344), ovariectomized | 0.005 g/kg | Diet | Female | 7 | 112/112 | Heart | lacI | - | [95] | |
| Uterus | lacI | - | [96] | |||||||
| Ethanol | Big Blue rat (F344) | 5 % | Drinking water | Male | 7–10 | 21/21 | Esophagus | lacI | - | [93] |
| Fructose | Big Blue rat (F344) | 30 % | Diet | Male | 9–12 | 35/35 | Liver | cII | - | [101] |
| Colon | cII | +− | Ibid | |||||||
| Furan | Big Blue rat (F344) | 30 mg/kg | Gavage | Male | 7 | 56/56 | Liver | cII | - | [187] |
| 16 mg/kg | Gavage | Male | 7 | 56/56 | Liver | cII | - | Ibid | ||
| 8 mg/kg | Gavage | Male | 7 | 56/56 | Liver | cII | - | Ibid | ||
| 2 mg/kg | Gavage | Male | 7 | 56/56 | Liver | cII | - | Ibid | ||
| Genistein | Big Blue rat (F344) | 1 g/kg | Diet | Female | 7 | 112/112 | Mammary gland | lacI | - | [95] |
| 7 | 112/112 | Liver | cII | - | [94] | |||||
| Uterus | lacI | - | [96] | |||||||
| 0.25 g/kg | Diet | Female | 7 | 112/112 | Mammary gland | lacI | - | [95] | ||
| Uterus | lacI | - | [96] | |||||||
| Big Blue rat (F344), ovariectomized | 1 g/kg | Diet | Female | 7 | 112/112 | Heart | lacI | - | [185] | |
| Uterus | lacI | - | [96] | |||||||
| Liver | cII | - | [94] | |||||||
| 0.25 g/kg | Diet | Female | 7 | 112/112 | Heart | lacI | - | [185] | ||
| Uterus | lacI | - | [96] | |||||||
| Glass wool fibres | Big Blue rat (F344) | 2 mg/rat | Intratracheal | Male | 11 | 1/28 | Lung | lacI | - | [127, 188] |
| 1/112 | Lung | lacI | - | Ibid | ||||||
| 2 mg/rat x4 | Intratracheal | Male | 11 | 28/56 | Lung | lacI | - | Ibid | ||
| 28/133 | Lung | lacI | - | Ibid | ||||||
| 1 mg/rat | Intratracheal | Male | 11 | 1/28 | Lung | lacI | - | Ibid | ||
| 1/112 | Lung | lacI | - | Ibid | ||||||
| Glucose | Big Blue rat (F344) | 30 % | Diet | Male | 9–12 | 35/35 | Liver | cII | - | [101] |
| Colon | cII | +− | Ibid | |||||||
| Glycidamide | Big Blue rat (F344) | 1.4 mM | Drinking water | Male | 7 | 60/60 | Liver | cII | - | [168] |
| Bone marrow | cII | + | Ibid | |||||||
| Thyroid | cII | + | Ibid | |||||||
| Testis | cII | - | Ibid | |||||||
| Female | 7 | 60/60 | Liver | cII | - | Ibid | ||||
| Bone marrow | cII | + | Ibid | |||||||
| Thyroid | cII | + | Ibid | |||||||
| Mammary gland | cII | - | Ibid | |||||||
| 0.7 mM | Drinking water | Male | 7 | 60/60 | Liver | cII | - | Ibid | ||
| Female | 7 | 60/60 | Liver | cII | - | Ibid | ||||
| Hexavalent chromium [Cr(VI)] (as sodium dichromate dihydrate) | Big Blue rat (F344) | 180 ppm (as Cr(VI)) | Drinking water | Male | 10 | 28/31 | Oral cavity (gingival/bubbal) | cII | - | [189] |
| Oral cavity (gingival/palate) | cII | - | Ibid | |||||||
| N-hydroxy-2-acetylaminofluorene | Big Blue rat (F344) | 25 mg/kg ×1 | Intraperitoneal | Male | 6 | 1/42 | Liver | lacI | + | [28, 190] |
| 25 mg/kg ×2 | Intraperitoneal | Male | 6 | 5/42 | Liver | lacI | + | Ibid | ||
| 25 mg/kg ×4 | Intraperitoneal | Male | 6 | 13/42 | Liver | lacI | + | Ibid | ||
| Spleen lymphocytes | lacI | + | Ibid | |||||||
| 4-Hydroxy-PCB3 (4-OH-PCB3) | Big Blue rat (F344) | 82 mg/kg ×4 | Intraperitoneal | Male | 6 | 22/38 | Liver | lacI | +− | [133] |
| Lung | lacI | +− | [135] | |||||||
| alpha-Hydroxytamoxifen | Big Blue rat (F344) | 54 μmol/kg ×21 | Intraperitoneal | Female | 8 | 21/51 | Liver | cII | + | [22] |
| Liver | lacI | + | [191] | |||||||
| Uterus | lacI | - | Ibid | |||||||
| 0.103 mmol/kg ×10 | Gavage | Female | 6–8 | 10/56 | Liver | lacI | + | [192] | ||
| Lard | Big Blue rat (F344) | 30 % | Diet | Male | 8 | 21/21 | Liver | cII | - | [193] |
| Colon | cII | - | Ibid | |||||||
| 10 % | Diet | Male | 8 | 21/21 | Liver | cII | - | Ibid | ||
| Colon | cII | - | Ibid | |||||||
| 3 % | Diet | Male | 8 | 21/21 | Liver | cII | - | Ibid | ||
| Colon | cII | - | Ibid | |||||||
| Leucomalachite green | Big Blue rat (F344) | 543 ppm | Diet | Female | 6 | 28/28 | Liver | lacI | - | [79] |
| 112/112 | Liver | lacI | - | [79, 81] | ||||||
| 224/224 | Liver | lacI | - | [79] | ||||||
| 272 ppm | Diet | Female | 6 | 28/28 | Liver | lacI | - | Ibid | ||
| 112/112 | Liver | lacI | - | Ibid | ||||||
| 224/224 | Liver | lacI | - | Ibid | ||||||
| 91 ppm | Diet | Female | 6 | 112/112 | Liver | lacI | - | Ibid | ||
| N-Methyl-amyl-nitrosamine | Big Blue rat (Sprague Dawley/Big Blue F1) | 25 mg/kg ×10 | Intraperitoneal | 10 | 64/70 | Esophagus | lacI | + | [194] | |
| 3-Methylcholanthrene | Big Blue rat (F344) | 80 mg/kg ×4 | Intraperitoneal | Male | 6 | 22/38 | Liver | lacI | + | [133] |
| Lung | lacI | + | [135] | |||||||
| 4-Monochlorobiphenyl (PCB3) | Big Blue rat (F344) | 113 mg/kg ×4 | Intraperitoneal | Male | 6 | 22/38 | Liver | lacI | + | [133] |
| Lung | lacI | + | [135] | |||||||
| Madder color and lucidin-3-O-primeveroside (LuP) | gpt delta rat (F344) | Madder color 5.0 % w/w | Diet | Male | 5 | 56/56 | Kidney | gpt, Spi− | + | [73] |
| LuP 0.3 % w/w | Diet | Male | 5 | 56/56 | Kidney | gpt, Spi− | + | Ibid | ||
| 3-MCPD | gpt delta rat (F344) | 40 mg/kg | Gavege | Male | 6 | 5 times per week x 4 weeks/1 | Kidney and testis | gpt, Spi− | - | [66] |
| the equimolar esters | Gavege | Male | 6 | Kidney and testis | gpt, Spi− | - | Ibid | |||
| Methyleugenol | gpt delta rat (F344) | 100 mg/kg | Gavage | Male and female | 5 | 91/91 | Liver | gpt, Spi− | + | [74] |
| 30 mg/kg | Gavage | Male and female | 5 | 91/91 | Liver | gpt, Spi− | - | Ibid | ||
| 10 mg/kg | Gavage | Male and female | 5 | 91/91 | Liver | gpt, Spi− | - | Ibid | ||
| Nickel subsulfide (Ni3S2) | Big Blue rat (F344) | 6 mg/kg (130 mg/m3), 2 h | Inhalation | Male | 9 | 1/14 | Lung | lacI | - | [123] |
| Nasal mucosa | lacI | - | Ibid | |||||||
| gpt delta rat (F344) | 1 mg/animal | Intratracheally instillation | Male | 12 | 28/28 | Lung | gpt, Spi− | - | [124] | |
| 0.5 mg/animal | Intratracheally instillation | Male | 12 | 28/28 | Lung | gpt, Spi− | - | Ibid | ||
| 1 mg/animal | Intratracheally instillation | Male | 12 | 90/90 | Lung | gpt, Spi− | - | ibid | ||
| 0.5 mg/animal | Intratracheally instillation | Male | 12 | 90/90 | Lung | gpt, Spi− | - | Ibid | ||
| N-nitrosomethylbenzylamine | Big Blue rat (F344) | 2 mg/kg ×2 | Subcutaneous | Male | 7–10 | 7/21 | Esophagus | lacI | + | [93] |
| 6-Nitrochrysene | Big Blue rat (F344 × SD)F1 | 100 μmole/rat x 8 | Oral | Female | 5 | 50/274 | Mammary gland | cII | + | [195] |
| 50 μmole/rat x 8 | Oral | Female | 5 | 50/274 | Mammary gland | cII | + | Ibid | ||
| N-nitrosopyrrolidine | gpt delta rat (SD) | 200 ppm | Drinking water | Female | 11 | 91/91 | Liver | gpt | + | [167] |
| 4-nitroquinoline-1-oxide | Big Blue rat (F344) | 10 ppm | Drinking water | Male | 10–11 | 28/31 | Oral cavity (gingival/bubbal) | cII | + | [196] |
| Oral cavity (gingival/palate) | cII | + | Ibid | |||||||
| Liver | cII | - | Ibid | |||||||
| Bone marrow | cII | - | Ibid | |||||||
| Big Blue rat (F344) | 10 ppm | Drinking water | Male | 10 | 28/31 | Oral cavity (gingival/bubbal) | cII | + | [189] | |
| Oral cavity (gingival/palate) | cII | + | Ibid | |||||||
| Ochratoxin A | gpt delta rat (F344) | 5 ppm | Diet | Male and female | 5 | 28/28 | outer medulla of kidney | gpt | - | [50] |
| Male and female | 5 | 28/28 | outer medulla of kidney | Spi− | + | Ibid | ||||
| Male and female | 5 | 91/91 | whole kidney | gpt, Spi− | - | ibid | ||||
| 5 ppm | Diet | Male | 5 | 28/28 | outer medulla of kidney | Spi− | + | [65] | ||
| Phenacetin | gpt delta rat (SD) | 0.50 % | Diet | Male and female | 7 | 182/182 | Kidney | gpt, Spi− | - | [52] |
| Male and female | 7 | 182/182 | Liver | gpt | + | Ibid | ||||
| Male and female | 7 | 182/182 | Liver | Spi− | - | ibid | ||||
| Male | 7 | 364/364 | Kidney | gpt | + | Ibid | ||||
| Male | 7 | 364/364 | Kideney | Spi− | - | Ibid | ||||
| Female | 7 | 364/364 | Kideney | gpt, Spi− | - | Ibid | ||||
| Male | 7 | 364/364 | Liver | gpt, Spi− | + | Ibid | ||||
| Female | 7 | 364/364 | Liver | gpt, Spi− | + | Ibid | ||||
| Potassium Bromate (KBrO3) | Big Blue rat (F344) | 500 ppm | Drinking water | Male | 6 | 112/112 | Kidney | lacI | + | [87] |
| 125 ppm | Drinking water | Male | 6 | 112/112 | Kidney | lacI | - | Ibid | ||
| 30 ppm | Drinking water | Male | 6 | 112/112 | Kidney | lacI | - | Ibid | ||
| 8 ppm | Drinking water | Male | 6 | 112/112 | Kidney | lacI | - | Ibid | ||
| 2 ppm | Drinking water | Male | 6 | 112/112 | Kidney | lacI | - | Ibid | ||
| 0.2 ppm | Drinking water | Male | 6 | 112/112 | Kidney | lacI | - | Ibid | ||
| 0.02 ppm | Drinking water | Male | 6 | 112/112 | Kidney | lacI | - | Ibid | ||
| 0.002 ppm | Drinking water | Male | 6 | 112/112 | Kidney | lacI | - | Ibid | ||
| gpt delta rat (SD) | 500 ppm | Drinking water | Male | 5 | 7/7 | Kidney | gpt | - | [119] | |
| Spi− | - | Ibid | ||||||||
| 35/35 | Kidney | gpt | - | Ibid | ||||||
| Spi− | - | Ibid | ||||||||
| 63/63 | Kidney | gpt | - | Ibid | ||||||
| Spi− | + | Ibid | ||||||||
| 91/91 | Kidney | gpt | - | Ibid | ||||||
| Spi− | + | Ibid | ||||||||
| 250 ppm | Drinking water | Male | 5 | 91/91 | Kidney | gpt | - | Ibid | ||
| Spi− | - | Ibid | ||||||||
| 125 ppm | Drinking water | Male | 5 | 91/91 | Kidney | gpt | - | Ibid | ||
| Spi− | - | Ibid | ||||||||
| 60 ppm | Drinking water | Male | 5 | 91/91 | Kidney | gpt | - | Ibid | ||
| Spi− | - | Ibid | ||||||||
| gpt delta rat (F344) | 500 ppm | Drinking water | Male | 5 | 63/63 | Kidney | gpt | - | [120] | |
| Spi− | - | Ibid | ||||||||
| Female | 5 | 63/63 | Kidney | gpt | + | Ibid | ||||
| Spi− | - | Ibid | ||||||||
| Riddelliine | Big Blue rat (F344) | 1.0 mg/kg ×5 ×12 | Gavage | Female | 6 | 82/83 | Liver | cII | + | [115] |
| 0.3 mg/kg ×5 ×12 | Gavage | Female | 6 | 82/83 | Liver | cII | + | ibid | ||
| 6 | 82/83 | Liver parenchymal cells | cII | - | [116] | |||||
| 6 | 82/83 | Liver endothelial cells | cII | + | Ibid | |||||
| 0.1 mg/kg ×5 ×12 | Gavage | Female | 6 | 82/83 | Liver | cII | + | [115] | ||
| Rock wool fibers | Big Blue rat (F344) | 2 mg/rat | Intratracheal | Male | 11 | 1/28 | Lung | lacI | - | [127, 188] |
| 1/112 | Lung | lacI | + | Ibid | ||||||
| 2 mg/rat ×4 | Intratracheal | Male | 11 | 28/56 | Lung | lacI | - | Ibid | ||
| 28/133 | Lung | lacI | + | ibid | ||||||
| 1 mg/rat | Intratracheal | Male | 11 | 1/28 | Lung | lacI | - | Ibid | ||
| 1/112 | Lung | lacI | + | Ibid | ||||||
| Selenium (as sodium selenite) with dimethylhydrazine (DMH) injection | Big Blue rat (F344) | 2 μg Se/g diet with DMH injection | Diet | 63–84/63–84 (DMH (25 mg/kg body weight, i.p., weekly, twice) was injected after 3 weeks of the diet. | Liver | cII | + | [197] | ||
| Colon | cII | + | Ibid | |||||||
| 0.2 μg Se/g diet with DMH injection | Diet | 63–84/63–84 (DMH (25 mg/kg body weight, i.p., weekly, twice) was injected after 3 weeks of the diet. | Liver | cII | + | Ibid | ||||
| Colon | cII | + | Ibid | |||||||
| *No effect of Se. | ||||||||||
| Sucrose | Big Blue rat (F344) | 30 % | Diet | Male | 9–12 | 35/35 | Liver | cII | - | [101] |
| Colon | cII | +− | Ibid | |||||||
| 34.50 % | Diet | Male | 8–12 | 21/21 | Liver | cII | - | [136] | ||
| Colon | cII | + | ibid | |||||||
| 13.80 % | Diet | Male | 8–12 | 21/21 | Liver | cII | - | Ibid | ||
| Colon | cII | + | Ibid | |||||||
| 6.90 % | Diet | Male | 8–12 | 21/21 | Liver | cII | - | Ibid | ||
| Colon | cII | - | Ibid | |||||||
| 13.40 % | Diet | Male | 9–12 | 21/21 | Liver | cII | - | [100] | ||
| Colon | cII | + | Ibid | |||||||
| 3.45 % | Diet | Male | 9–12 | 21/21 | Liver | cII | - | Ibid | ||
| Colon | cII | + | Ibid | |||||||
| 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) | Big Blue rat (F344) | 2 μig/kg ×12 | Gavage | Male | 8 | 42/56 | Liver | lacI | - | [128] |
| Female | 8 | 42/56 | Liver | lacI | - | Ibid | ||||
| Tamoxifen | Big Blue rat (F344) | 54 μmol/kg ×21 | Intraperitoneal | Female | 8 | 21/51 | Liver | cII | + | [22] |
| Liver | lacI | + | [191] | |||||||
| Uterus | lacI | - | Ibid | |||||||
| 20 mg/kg ×42 | Gavage | Female | 6–8, 16–18 | 42/56 | Liver | lacI | + | [170] | ||
| cII | + | [109] | ||||||||
| 6–8 | 42/42 | Liver | lacI | + | [110] | |||||
| 42/56 | Liver | lacI | + | Ibid | ||||||
| 42/126 | Liver | lacI | + | Ibid | ||||||
| 42/210 | Liver | lacI | + | Ibid | ||||||
| 10 mg/kg ×42 | Gavage | Female | 6–8 | 42/56 | Liver | lacI | + | [170] | ||
| cII | +− | [109] | ||||||||
| gpt delta rat (F344) | 40 mg/kg | Gavege | Female | 21/21 | Liver | gpt, Spi− | + | [58] | ||
| Gavege | Female | 21/21 | Kidney | gpt, Spi− | - | Ibid | ||||
| 20 mg/kg | Gavege | Female | 21/21 | Liver | gpt, Spi− | + | Ibid | |||
| Gavege | Female | 21/21 | Kidney | gpt, Spi− | - | Ibid | ||||
| 500 ppm | Diet | Female | 91/91 | Liver | gpt, Spi− | + | Ibid | |||
| Diet | Female | 91/91 | Kidney | gpt, Spi− | - | Ibid | ||||
| 250 ppm | Diet | Female | 91/91 | Liver | gpt, Spi− | + | Ibid | |||
| Diet | Female | 91/91 | Kidney | gpt, Spi− | - | Ibid | ||||
| Thiotepa Toremifene | Big Blue rat (F344) | 1.4 mg/kg ×12 | Intraperitoneal | Male | 7 | 28/35 | Spleen lymphocytes | lacI | + | [29] |
| Big Blue rat (F344) | 20 mg/kg ×42 | Gavage | Female | 6–8 | 42/56 | Liver | lacI | - | [170] | |
| gpt delta rat (F344) | 40 mg/kg | Gavege | Female | 21/21 | Liver | gpt, Spi− | - | [58] | ||
| Gavege | Female | 21/21 | Kidney | gpt, Spi− | - | Ibid | ||||
| Tris(2,3-dibromopropyl)phosphate (TDBP) | Big Blue rat (F344) | 2000 ppm | Diet | Male | 6–8 | 45/45 | Kidney (outer medulla) | lacI | + | [47] |
| Kidney (inner medulla) | lacI | + | Ibid | |||||||
| Kidney (cortex) | lacI | + | Ibid | |||||||
| 100 ppm | Diet | Male | 6–8 | 45/45 | Kidney (outer medulla) | lacI | + | Ibid | ||
| Kidney (inner medulla) | lacI | + | Ibid | |||||||
| Kidney (cortex) | lacI | + | Ibid | |||||||
| Uracil | Big Blue rat (F344) | 3 % | Diet | Male | 6 | 14/14 | Bladder | lacI | - | [25] |
| 70/70 | Bladder | lacI | + | Ibid | ||||||
| 140/140 | Bladder | lacI | + | Ibid | ||||||
| 357/357 | Bladder | lacI | + | Ibid | ||||||